0000899243-18-031089.txt : 20181214
0000899243-18-031089.hdr.sgml : 20181214
20181214163334
ACCESSION NUMBER: 0000899243-18-031089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181213
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PIKOVER YURI
CENTRAL INDEX KEY: 0001032389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 181235974
MAIL ADDRESS:
STREET 1: C/O XLAN CORP
STREET 2: 26679 WEST AGOURA ROAD
CITY: CALABASAS
STATE: CA
ZIP: 91302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-614-1848
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-13
0
0001160308
Savara Inc
SVRA
0001032389
PIKOVER YURI
6836 BEE CAVE ROAD, BUILDING III
SUITE 200
AUSTIN
TX
78746
1
0
0
0
Stock Option (Right to Buy)
7.33
2018-12-13
4
A
0
12000
0.00
A
2028-12-13
Common Stock
12000
12000
D
The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer.
/s/ David Lowrance as attorney-in-fact for Yuri Pikover
2018-12-14